At the top of the list is Amgen, trying to hold on amidst recent news and studies…1 billion is a lot of money. BD
The big health-policy debates roiling Washington are still up in the air, but it’s already clear who the big winners are: Lobbyists.
The pharmaceutical industry spent $168 million on lobbying last year, up 32% from the year before, says a report out today from the nonprofit Center for Public Integrity. Over the past decade, the drug and device industries have collectively spent more than $1 billion on lobbying, the group said.
http://blogs.wsj.com/health/2008/06/24/which-drug-companies-spend-the-most-on-lobbying/